Increased mortality in patients with COVID-19 receiving extracorporeal respiratory support during the second wave of the pandemic

Autores da FMUP

• Roberto Liberal Fernandes Roncon Albuquerque

  Autor

Participantes de fora da FMUP

• Riera, J
• Fuset, MP
• Alcantara, S
• Blanco Schweizer, PAB -

Unidades de investigação

• Cirurgia e Fisiologia

• Laboratório Associado RISE- Rede de Investigação em Saúde

  

  Investigador

  Fernando Carlos De Landér Schmitt

• RISE-Health

  

  Investigador

  Fernando Carlos De Landér Schmitt

Abstract

[No abstract available]

Keywords

• COVID-19; Extracorporeal Membrane Oxygenation; Humans; Pandemics; Respiratory Distress Syndrome; SARS-CoV-2; anticoagulant agent; dexamethasone; methylprednisolone; tocilizumab; acute kidney failure; adult respiratory distress syndrome; coinfection; coronavirus disease 2019; extracorporeal oxygenation; female; hemorrhagic shock; hospital mortality; human; intensive care unit; Letter; major clinical study; male; pandemic; pneumonia; thrombosis; adverse event; respiratory distress syndrome